Literature DB >> 25463486

Effect of fetal bovine serum on mineralization in silk fibroin scaffolds.

Jolanda R Vetsch1, Samantha J Paulsen1, Ralph Müller1, Sandra Hofmann2.   

Abstract

Fetal bovine serum (FBS) is a common media supplement used in tissue engineering (TE) cultures. The chemical composition of FBS is known to be highly variable between different brands, types or batches and can have a significant impact on cell function. This study investigated the influence of four different FBS types in osteogenic or control medium on mineralization of acellular and cell-seeded silk fibroin (SF) scaffolds. In bone TE, mineralized tissue is considered as the final product of a successful cell culture. Calcium assays and micro-computed tomography scans revealed spontaneous mineralization on SF scaffolds with certain FBS types, even without cells present. In contrast, cell-mediated mineralization was found under osteogenic conditions only. Fourier transform infrared spectroscopy analysis demonstrated a similar ion composition of the mineralization present in scaffolds, whether cell-mediated or spontaneous. These results were confirmed by scanning electron microscopy. This study shows clear evidence for the influence of FBS type on mineralization on SF scaffolds. The suitability of FBS medium supplementation in TE studies is highly questionable with regard to reproducibility of studies and comparability of obtained results. For future TE studies, alternatives to conventional FBS such as defined FBS or serum-free media should be considered, as suggested decades ago.
Copyright © 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone tissue engineering; Fetal bovine serum; Scaffolds; Silk fibroin; Spontaneous mineralization

Mesh:

Substances:

Year:  2014        PMID: 25463486     DOI: 10.1016/j.actbio.2014.11.025

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  8 in total

1.  The influence of curvature on three-dimensional mineralized matrix formation under static and perfused conditions: an in vitro bioreactor model.

Authors:  Jolanda R Vetsch; Ralph Müller; Sandra Hofmann
Journal:  J R Soc Interface       Date:  2016-10       Impact factor: 4.118

2.  Human Platelet Lysate as Alternative of Fetal Bovine Serum for Enhanced Human In Vitro Bone Resorption and Remodeling.

Authors:  Bregje W M de Wildt; Keita Ito; Sandra Hofmann
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

3.  A novel silk fibroin nanofibrous membrane for guided bone regeneration: a study in rat calvarial defects.

Authors:  Shijun Lu; Peng Wang; Feng Zhang; Xichao Zhou; Baoqi Zuo; Xinran You; Yang Gao; Hongchen Liu; Hailiang Tang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

Review 4.  Strategy for achieving standardized bone models.

Authors:  Mikhael Hadida; David Marchat
Journal:  Biotechnol Bioeng       Date:  2019-10-09       Impact factor: 4.530

5.  Time-lapsed imaging of nanocomposite scaffolds reveals increased bone formation in dynamic compression bioreactors.

Authors:  Gian Nutal Schädli; Jolanda R Vetsch; Robert P Baumann; Anke M de Leeuw; Esther Wehrle; Marina Rubert; Ralph Müller
Journal:  Commun Biol       Date:  2021-01-25

6.  Alkaline Phosphatase Activity of Serum Affects Osteogenic Differentiation Cultures.

Authors:  Sana Ansari; Keita Ito; Sandra Hofmann
Journal:  ACS Omega       Date:  2022-04-04

7.  In Vitro Biodegradation of a-C:H:SiOx Films on Ti-6Al-4V Alloy.

Authors:  Alexander Grenadyorov; Andrey Solovyev; Konstantin Oskomov; Ekaterina Porokhova; Konstantin Brazovskii; Anna Gorokhova; Temur Nasibov; Larisa Litvinova; Igor Khlusov
Journal:  Materials (Basel)       Date:  2022-06-15       Impact factor: 3.748

8.  Electrospun silk fibroin/poly(lactide-co-ε-caprolactone) nanofibrous scaffolds for bone regeneration.

Authors:  Zi Wang; Ming Lin; Qing Xie; Hao Sun; Yazhuo Huang; DanDan Zhang; Zhang Yu; Xiaoping Bi; Junzhao Chen; Jing Wang; Wodong Shi; Ping Gu; Xianqun Fan
Journal:  Int J Nanomedicine       Date:  2016-04-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.